Investigation of Blood Glucose and Insulin Response After Intake of Vitalose
NCT ID: NCT04596709
Last Updated: 2020-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2020-10-22
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitalose
dissolved in water
Vitalose
dissolved in water
isomaltulose
dissolved in water
isomaltulose
dissolved in water
sucrose
dissolved in water
sucrose
dissolved in water
glucose
dissolved in water
glucose
dissolved in water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitalose
dissolved in water
isomaltulose
dissolved in water
sucrose
dissolved in water
glucose
dissolved in water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-50 years
* BMI ≥18.5 and ≤30.0 kg/m²
Exclusion Criteria
* food allergy or intolerance
* intake of medications which affect glucose tolerance
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioTeSys GmbH
OTHER
Beneo-Institute
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Menzel, Dr.
Role: PRINCIPAL_INVESTIGATOR
BioTeSys GmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BioTeSys GmbH
Esslingen am Neckar, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BTS1586/20
Identifier Type: -
Identifier Source: org_study_id